All Articles

  2. All Articles

ANALYSIS OF COMORBIDITY IN COMMUNITY-ACQUIRED PNEUMONIA ASSOCIATED WITH COVID-19

Chaban I. V., Marushchak M. I.
2024 Issue 2, 173 arterial hypertension cardiovascular diseases COVID-19 pneumonia prevalence

SURGICAL TREATMENT OF ANOMALOUS LEFT CORONARY ARTERY FROM THE PULMONARY ARTERY

Fozekosh A. A., Truba Ia. P., Dziuryi I. V., Perepeka I. A., Lazoryshynets V. V
2024 Issue 2, 173 anomalous left coronary artery Bland-White-Garland syndrome congenital heart disease left ventricular dysfunction mitral insufficiency

EFFICIENCY OF QUERCETIN AND TRIMETASIDINE IN PATIENTS WITH COVID-19 AND CONCOMITANT CHRONIC CORONARY SYNDROME: EFFECT ON SYSTEMIC INFLAMMATION

Tomyn I. V., Fedorov S. V.
2024 Issue 2, 173 coronary heart disease COVID-19 inflammation quercetin trimetazidine

THE ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND INTERLEUKIN-6 IN THE FORMATION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH MULTIPLE SCLEROSIS

Teslenko O. S., Tovazhnyanska O. L.
2024 Issue 2, 173 BDNF cognitive impairment interleukin-6 multiple sclerosis neurocognitive testing

ASSOCIATION OF ACHIEVEMENT/FAILURE OF THE TARGET LEVEL OF BLOOD PRESSURE AND ADHERENCE TO ANTIHYPERTENSIVE TREATMENT IN OUTPATIENTS WITH ISOLATED ARTERIAL HYPERTENSION AND IN COMBINATION WITH CARDIOVASCULAR COMORBIDITY

Stanovska L. V., Krynytska I. Ya.
2024 Issue 2, 173 adherence to antihypertensive treatment arterial hypertension cardiovascular comorbidity target blood pressure level

LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 2A (CALPAINOPATHY): CLINICAL OBSERVATION

Synhaivskyi A. M., Delva M. Yu., Purdenko T. Y., Pushko O. O., Tarianyk K. A., Sylenko H. Ya., Hryn K. V.
2024 Issue 2, 173 calpainopathy diagnosis limb-girdle muscular dystrophy treatment